Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2007 1
2008 4
2009 2
2010 1
2011 2
2012 1
2013 2
2014 6
2015 4
2016 4
2017 6
2018 3
2019 4
2020 1
2021 7
2022 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
MiR-29 and MiR-140 regulate TRAIL-induced drug tolerance in lung cancer.
Kim S, Lee KW, Yoo Y, Park SH, Lee JW, Jeon S, Illia S, Joshi P, Park HW, Lo HE, Seo J, Kim Y, Chang M, Lee TJ, Seo JB, Kim SH, Croce CM, Kim I, Suh SS, Jeon YJ. Kim S, et al. Among authors: suh ss. Anim Cells Syst (Seoul). 2024 Apr 30;28(1):184-197. doi: 10.1080/19768354.2024.2345644. eCollection 2024. Anim Cells Syst (Seoul). 2024. PMID: 38693921 Free PMC article.
Lucidumol A, Purified Directly from Ganoderma lucidum, Exhibits Anticancer Effect and Cellular Inflammatory Response in Colorectal Cancer.
Shin MJ, Chae HJ, Lee JW, Koo MH, Kim HJ, Seo JB, yanIllia S, Park SH, Lo HE, Kim SH, Youn UJ, Jeon YJ, Suh SS. Shin MJ, et al. Among authors: suh ss. Evid Based Complement Alternat Med. 2022 Nov 8;2022:7404493. doi: 10.1155/2022/7404493. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36397994 Free PMC article.
Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation.
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM. Garofalo M, et al. Among authors: suh ss. Cancer Cell. 2022 Nov 14;40(11):1440. doi: 10.1016/j.ccell.2022.10.005. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306794 Free PMC article. No abstract available.
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM. Pichiorri F, et al. Among authors: suh ss. Cancer Cell. 2022 Nov 14;40(11):1441. doi: 10.1016/j.ccell.2022.10.006. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306793 Free PMC article. No abstract available.
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM. Pichiorri F, et al. Among authors: suh ss. Cancer Cell. 2022 Nov 14;40(11):1442. doi: 10.1016/j.ccell.2022.10.007. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306791 Free article. No abstract available.
59 results